SlideShare a Scribd company logo
1 of 31
Chapter 45 
Drugs Treating Viral Infections 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• The transcription phase of viral replication involves the 
change of RNA to DNA. 
– A. True 
– B. False
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• A. True 
• Rationale: Transcription involves the change of 
ribonucleic acid (RNA) to deoxyribonucleic acid 
(DNA).
Physiology of Viral Reproduction 
• The reproduction of viruses in humans requires five 
steps: 
– Adsorption 
– Penetration 
– Uncoating 
– Replication 
– Transcription 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Viral Reproduction 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pathophysiology of Selected Viral 
Infections 
• Cytomegalovirus (CMV) 
– Type of herpesvirus 
– Asymptomatic in most individuals 
– Patients with AIDS or bone marrow transplant 
recipients, CMV can be fatal. 
– CMV infection during pregnancy may lead to birth 
defect or stillborn. 
– Most frequently causes retinitis, but also infects 
lungs, throat, brain, kidneys, gallbladder, liver, and 
colon 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pathophysiology of Selected Viral 
Infections (cont.) 
• Hepatitis 
– Five types: HAV, HBV, HCV, HDV, and HEV 
– Most common in the United States: HAV, HBV, and 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
HCV 
– Symptoms include jaundice, fatigue, abdominal pain, 
nausea, and anorexia. 
– HAV: spread via oral–fecal route 
– HBV and HCV: spread via blood or body fluids
Pathophysiology of Selected Viral 
Infections (cont.) 
• Herpes simplex (HSV) 
– Two types: HSV-1 and HSV-2 
– Characterized by the formation of painful vesicles; 
HSV-1 on or near the mouth, HSV-2 in the genital 
region 
• Herpes zoster 
– Acute unilateral and segmental inflammation of the 
dorsal root ganglia caused by infection with the 
herpesvirus varicella zoster (chickenpox) 
– Follow dermatomes of trunk and occasionally on 
arms and legs 
– Postherpetic neuralgia is common complication. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Pathophysiology of Selected Viral 
Infections (cont.) 
• Influenza 
– Attacks both the upper and the lower respiratory tracts 
– A and B only types affected by current antiviral agents 
• Respiratory syncytial virus (RSV) 
– A major cause of respiratory illness in all age groups 
– Highest rates of RSV illness occur in infants 2 to 6 
months of age 
– Symptoms include hacking cough and wheezing on 
exhalation. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• Hepatitis A is spread through blood and body fluids that 
contain blood. 
– A. True 
– B. False
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• B. False 
• Rationale: Hepatitis A is spread by the oral and fecal 
route, not through blood or body fluids that contain 
blood.
Purine Nucleoside Analogue Drugs 
• The largest group of antiviral drugs is the purine 
nucleoside analogue drugs. 
• They have relatively selective toxicity to viruses because 
viral DNA polymerases are more sensitive than human 
polymerases to inhibition by these drugs. 
• Prototype drug: acyclovir (Zovirax) 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Core Drug Knowledge 
• Pharmacotherapeutics 
– Treatment of herpesviruses 
• Pharmacokinetics 
– Administered: topical, oral, or IV 
• Pharmacodynamics 
– Undergoes phosphorylation. In an infected cell, it is 
converted by the viral enzyme thymidine kinase. 
Once incorporated into the virus, it terminates DNA 
synthesis. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Core Drug Knowledge (cont.) 
• Contraindications and precautions 
– Use caution in patients with ganciclovir 
hypersensitivity 
• Adverse effects 
– Light-headedness, anorexia, nausea, vomiting, 
abdominal pain, and headache 
• Drug interactions 
– Valproic acid, hydantoins, theophyllines, and 
probenecid 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Core Patient Variables 
• Health status 
– Assess medical history and function of kidneys. 
• Life span and gender 
– Pregnancy Category C drug 
• Lifestyle, diet, and habits 
– Can transmit disease to others 
• Environment 
– Assess the environment where the drug will be given. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Nursing Diagnoses and 
Outcomes 
• Disturbed Thought Processes related to drug-induced 
confusion, hallucinations, or seizures 
– Desired outcome: The patient will be free of 
thought aberrations related to drug therapy. 
• Acute Pain related to drug-induced headache 
– Desired outcome: Drug-related pain will subside 
after administration of acetaminophen. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Nursing Diagnoses and 
Outcomes (cont.) 
• Imbalanced nutrition: Less than Body Requirements, 
related to acyclovir-related anorexia, nausea and 
vomiting, or abdominal pain 
– Desired outcome: The patient will remain within an 
acceptable weight range. 
• Excess Fluid Volume related to adverse effects of drug 
therapy, such as nephrotoxicity 
– Desired outcome: The patient will have an 
adequate fluid intake and output profile. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Planning and Interventions 
• Maximizing therapeutic effects 
– Administer acyclovir tablets or capsules with a full 
glass of water, with or without food. 
• Minimizing adverse effects 
– Advise the patient to drink at least 8-oz glasses of 
water a day. 
– Administer IV acyclovir over 60 minutes. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Acyclovir: Teaching, Assessment, and 
Evaluations 
• Patient and family education 
– Advise patients to notify the prescriber if they are 
pregnant or breast-feeding. 
– Emphasize that acyclovir does not prevent the 
transmission of infection to another person and does 
not cure the infection. 
• Ongoing assessment and evaluation 
– Monitor for the effectiveness of therapy, making sure 
to document new lesions and assess for possible 
secondary bacterial infections. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• IV acyclovir is associated with which of the following 
adverse reaction(s)? 
– A. Hepatotoxicity 
– B. Hallucinations 
– C. Nephrotoxicity 
– D. Seizures 
– E. Both B and D
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• C. Nephrotoxicity 
• Rationale: Acyclovir nephrotoxicity appears to result 
from crystallization of the drug in the nephron, which 
can lead to renal tubular obstruction.
Drugs Used for Influenza 
• Influenza can be a debilitating virus. 
• It generally subsides without pharmacotherapy. 
• Certain populations require treatment due to possible 
life-threatening symptoms. 
• Prototype: oseltamivir (Tamiflu) 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Oseltamivir: Core Drug Knowledge 
• Pharmacotherapeutics 
– A neuraminidase inhibitor; used to manage influenza 
A or B virus; drug of choice for H5N1 and H1N1 
• Pharmacokinetics 
– Metabolized: oseltamivir carboxylate. Excreted: 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
kidneys. 
• Pharmacodynamics 
– Appears to inhibit the release of viruses from infected 
cells, reducing spread to adjacent cells
Oseltamivir: Core Drug Knowledge (cont.) 
• Contraindications and precautions 
– Hypersensitivity, pregnancy, breast-feeding, asthma, 
CAL, renal insufficiency 
• Adverse effects 
– Nausea and vomiting, bronchitis, insomnia, vertigo 
• Drug interactions 
– No known significant drug–drug interactions 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Oseltamivir: Core Patient Variables 
• Health status 
– Assess for influenza symptoms. 
• Life span and gender 
– Pregnancy Category C drug 
• Lifestyle, diet, and habits 
– Assess for history of fructose intolerance. 
• Environment 
– Assess where the patient will be receiving the drug. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Oseltamivir: Nursing Diagnoses and 
Outcomes 
• Disturbed Thought Processes related to drug-induced 
confusion, hallucinations, or seizures 
– Desired outcome: The patient will be free of 
thought aberrations related to drug therapy. 
• Risk for Injury related to abnormal behaviors 
– Desired outcome: The patient will remain free from 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
injury.
Oseltamivir: Nursing Diagnoses and 
Outcomes (cont.) 
• Imbalanced nutrition: Less than Body Requirements, 
related to anorexia, nausea and vomiting, or abdominal 
pain 
– Desired outcome: The patient will remain within an 
acceptable weight range. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Oseltamivir: Planning and Intervention 
• Maximizing therapeutic effects 
– Works best when started within 48 hrs of onset of 
symptoms 
– Prepare and store solution correctly. 
• Minimizing adverse effects 
– Reduce nausea and vomiting by administrating the 
drug with milk, a snack, or a meal. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Oseltamivir: Teaching, Assessment, and 
Evaluations 
• Patient and family education 
– Instruct on the correct usage. 
– Encourage the patient to complete the full course. 
• Ongoing assessment and evaluation 
– Monitor for adverse effects. 
– Assess for resolution of symptoms. 
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Question 
• Which of the following symptoms are common for 
influenza? 
– A. Fever 
– B. Joint aches 
– C. Headache 
– D. All of the above
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins 
Answer 
• D. All of the above 
• Rationale: Common signs and symptoms for 
influenza can include sudden onset, fever, dry cough, 
headache, muscle and joint aches, fatigue and 
weakness, extreme exhaustion, chest discomfort, 
stuffy nose, sneezing, and sore throat.

More Related Content

What's hot

Ppt chapter 07-1
Ppt chapter 07-1Ppt chapter 07-1
Ppt chapter 07-1stanbridge
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37stanbridge
 
Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02stanbridge
 
Ppt chapter 05
Ppt chapter 05Ppt chapter 05
Ppt chapter 05stanbridge
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1stanbridge
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24stanbridge
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16stanbridge
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18stanbridge
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13stanbridge
 
Ppt chapter 23
Ppt chapter 23Ppt chapter 23
Ppt chapter 23stanbridge
 
Ppt chapter 06
Ppt chapter 06Ppt chapter 06
Ppt chapter 06stanbridge
 
Ppt chapter 17
Ppt chapter 17Ppt chapter 17
Ppt chapter 17stanbridge
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34stanbridge
 
Ppt chapter 01-1
Ppt chapter 01-1Ppt chapter 01-1
Ppt chapter 01-1stanbridge
 
Ppt chapter 10-1
Ppt chapter 10-1Ppt chapter 10-1
Ppt chapter 10-1stanbridge
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50stanbridge
 
Ppt chapter 15
Ppt chapter 15Ppt chapter 15
Ppt chapter 15stanbridge
 
Ppt chapter 12
Ppt chapter 12Ppt chapter 12
Ppt chapter 12stanbridge
 
Ppt chapter 15-1
Ppt chapter 15-1Ppt chapter 15-1
Ppt chapter 15-1stanbridge
 

What's hot (20)

Ppt chapter 07-1
Ppt chapter 07-1Ppt chapter 07-1
Ppt chapter 07-1
 
Ppt chapter 37
Ppt chapter 37Ppt chapter 37
Ppt chapter 37
 
Ppt chapter 02
Ppt chapter 02Ppt chapter 02
Ppt chapter 02
 
Ppt chapter 05
Ppt chapter 05Ppt chapter 05
Ppt chapter 05
 
Ppt chapter 24-1
Ppt chapter 24-1Ppt chapter 24-1
Ppt chapter 24-1
 
Ppt chapter 24
Ppt chapter 24Ppt chapter 24
Ppt chapter 24
 
Ppt chapter 16
Ppt chapter 16Ppt chapter 16
Ppt chapter 16
 
Ppt chapter 18
Ppt chapter 18Ppt chapter 18
Ppt chapter 18
 
Ppt chapter 13
Ppt chapter 13Ppt chapter 13
Ppt chapter 13
 
Ppt chapter 23
Ppt chapter 23Ppt chapter 23
Ppt chapter 23
 
Ppt chapter 06
Ppt chapter 06Ppt chapter 06
Ppt chapter 06
 
Ppt chapter 17
Ppt chapter 17Ppt chapter 17
Ppt chapter 17
 
Ppt chapter 34
Ppt chapter 34Ppt chapter 34
Ppt chapter 34
 
Ppt chapter 01-1
Ppt chapter 01-1Ppt chapter 01-1
Ppt chapter 01-1
 
Ppt chapter 10-1
Ppt chapter 10-1Ppt chapter 10-1
Ppt chapter 10-1
 
Ppt chapter 50
Ppt chapter 50Ppt chapter 50
Ppt chapter 50
 
Ppt chapter 15
Ppt chapter 15Ppt chapter 15
Ppt chapter 15
 
Ppt chapter 12
Ppt chapter 12Ppt chapter 12
Ppt chapter 12
 
Ppt chapter 15-1
Ppt chapter 15-1Ppt chapter 15-1
Ppt chapter 15-1
 
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
 

Viewers also liked

Viral infections ug lecture 2003
Viral infections ug lecture 2003Viral infections ug lecture 2003
Viral infections ug lecture 2003Lakshmi Mahadevan
 
Viral infections / 4th stage students / Dr. Alaa Awn
Viral infections / 4th stage students / Dr. Alaa AwnViral infections / 4th stage students / Dr. Alaa Awn
Viral infections / 4th stage students / Dr. Alaa AwnALAA AWN
 
Viral & Bacterial Infections 2
Viral & Bacterial  Infections 2Viral & Bacterial  Infections 2
Viral & Bacterial Infections 2MD Specialclass
 
Viral skin infection
Viral skin infectionViral skin infection
Viral skin infectionJason Sulit
 
viral diseases
viral diseasesviral diseases
viral diseaseskundana
 
Pathogenesis Virus
Pathogenesis VirusPathogenesis Virus
Pathogenesis Virusraj kumar
 
Bacterial, Viral & Mycotic Infections
Bacterial, Viral & Mycotic InfectionsBacterial, Viral & Mycotic Infections
Bacterial, Viral & Mycotic Infectionsguest018923
 
Viral infections of oral cavity - Dr. Abhishek Solanki
Viral infections of oral cavity - Dr. Abhishek SolankiViral infections of oral cavity - Dr. Abhishek Solanki
Viral infections of oral cavity - Dr. Abhishek SolankiAbhishek Solanki
 

Viewers also liked (11)

Viral infections ug lecture 2003
Viral infections ug lecture 2003Viral infections ug lecture 2003
Viral infections ug lecture 2003
 
Viral infections / 4th stage students / Dr. Alaa Awn
Viral infections / 4th stage students / Dr. Alaa AwnViral infections / 4th stage students / Dr. Alaa Awn
Viral infections / 4th stage students / Dr. Alaa Awn
 
Viral disease
Viral diseaseViral disease
Viral disease
 
Viral & Bacterial Infections 2
Viral & Bacterial  Infections 2Viral & Bacterial  Infections 2
Viral & Bacterial Infections 2
 
Viral skin infection
Viral skin infectionViral skin infection
Viral skin infection
 
viral diseases
viral diseasesviral diseases
viral diseases
 
Pathogenesis Virus
Pathogenesis VirusPathogenesis Virus
Pathogenesis Virus
 
Patogenesis viral
Patogenesis viralPatogenesis viral
Patogenesis viral
 
Viral diseases (3)
Viral diseases (3)Viral diseases (3)
Viral diseases (3)
 
Bacterial, Viral & Mycotic Infections
Bacterial, Viral & Mycotic InfectionsBacterial, Viral & Mycotic Infections
Bacterial, Viral & Mycotic Infections
 
Viral infections of oral cavity - Dr. Abhishek Solanki
Viral infections of oral cavity - Dr. Abhishek SolankiViral infections of oral cavity - Dr. Abhishek Solanki
Viral infections of oral cavity - Dr. Abhishek Solanki
 

Similar to Ppt chapter 45

Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41stanbridge
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20stanbridge
 
Ppt chapter 32
Ppt chapter 32Ppt chapter 32
Ppt chapter 32stanbridge
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36stanbridge
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22stanbridge
 
Ppt chapter 53-1
Ppt chapter 53-1Ppt chapter 53-1
Ppt chapter 53-1stanbridge
 
Ppt chapter 23-1
Ppt chapter 23-1Ppt chapter 23-1
Ppt chapter 23-1stanbridge
 
Chapter 14 ppt
Chapter 14 pptChapter 14 ppt
Chapter 14 pptstanbridge
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1stanbridge
 
Ppt chapter 49
Ppt chapter 49Ppt chapter 49
Ppt chapter 49stanbridge
 
Viral hepatitis presentation
Viral hepatitis presentationViral hepatitis presentation
Viral hepatitis presentationZeelNaik2
 
Cephalosporin
CephalosporinCephalosporin
Cephalosporindiorage
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21stanbridge
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21stanbridge
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1stanbridge
 
Ppt chapter 11-1
Ppt chapter 11-1Ppt chapter 11-1
Ppt chapter 11-1stanbridge
 
Ppt chapter 03
Ppt chapter 03Ppt chapter 03
Ppt chapter 03stanbridge
 

Similar to Ppt chapter 45 (20)

Ppt chapter 41
Ppt chapter 41Ppt chapter 41
Ppt chapter 41
 
Ppt chapter 35
Ppt chapter 35Ppt chapter 35
Ppt chapter 35
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 20
Ppt chapter 20Ppt chapter 20
Ppt chapter 20
 
Ppt chapter 32
Ppt chapter 32Ppt chapter 32
Ppt chapter 32
 
Ppt chapter 36
Ppt chapter 36Ppt chapter 36
Ppt chapter 36
 
Ppt chapter 22
Ppt chapter 22Ppt chapter 22
Ppt chapter 22
 
Ppt chapter 53-1
Ppt chapter 53-1Ppt chapter 53-1
Ppt chapter 53-1
 
Ppt chapter 23-1
Ppt chapter 23-1Ppt chapter 23-1
Ppt chapter 23-1
 
Chapter 14 ppt
Chapter 14 pptChapter 14 ppt
Chapter 14 ppt
 
Ppt chapter 26-1
Ppt chapter 26-1Ppt chapter 26-1
Ppt chapter 26-1
 
Ppt chapter 49
Ppt chapter 49Ppt chapter 49
Ppt chapter 49
 
Viral hepatitis presentation
Viral hepatitis presentationViral hepatitis presentation
Viral hepatitis presentation
 
Cephalosporin
CephalosporinCephalosporin
Cephalosporin
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21
 
Ppt chapter 21
Ppt chapter 21Ppt chapter 21
Ppt chapter 21
 
Ppt chapter 36-1
Ppt chapter 36-1Ppt chapter 36-1
Ppt chapter 36-1
 
Ppt chapter 11-1
Ppt chapter 11-1Ppt chapter 11-1
Ppt chapter 11-1
 
Ppt chapter 03
Ppt chapter 03Ppt chapter 03
Ppt chapter 03
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 

More from stanbridge

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecturestanbridge
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2stanbridge
 
Creating a poster
Creating a posterCreating a poster
Creating a posterstanbridge
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Disseminationstanbridge
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5stanbridge
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4stanbridge
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors stanbridge
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learnerstanbridge
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policystanbridge
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentstanbridge
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005stanbridge
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007stanbridge
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006stanbridge
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004stanbridge
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009stanbridge
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008stanbridge
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21stanbridge
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22stanbridge
 

More from stanbridge (20)

Micro Lab 3 Lecture
Micro Lab 3 LectureMicro Lab 3 Lecture
Micro Lab 3 Lecture
 
Creating a poster v2
Creating a poster v2Creating a poster v2
Creating a poster v2
 
Creating a poster
Creating a posterCreating a poster
Creating a poster
 
Sample poster
Sample posterSample poster
Sample poster
 
OT 5018 Thesis Dissemination
OT 5018 Thesis DisseminationOT 5018 Thesis Dissemination
OT 5018 Thesis Dissemination
 
Ot5101 005 week 5
Ot5101 005 week 5Ot5101 005 week 5
Ot5101 005 week 5
 
Ot5101 005 week4
Ot5101 005 week4Ot5101 005 week4
Ot5101 005 week4
 
Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors Compliance, motivation, and health behaviors
Compliance, motivation, and health behaviors
 
Ch 5 developmental stages of the learner
Ch 5   developmental stages of the learnerCh 5   developmental stages of the learner
Ch 5 developmental stages of the learner
 
OT 5101 week2 theory policy
OT 5101 week2 theory policyOT 5101 week2 theory policy
OT 5101 week2 theory policy
 
OT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessmentOT 5101 week3 planning needs assessment
OT 5101 week3 planning needs assessment
 
Ot5101 week1
Ot5101 week1Ot5101 week1
Ot5101 week1
 
NUR 304 Chapter005
NUR 304 Chapter005NUR 304 Chapter005
NUR 304 Chapter005
 
NUR 3043 Chapter007
NUR 3043 Chapter007NUR 3043 Chapter007
NUR 3043 Chapter007
 
NUR 3043 Chapter006
NUR 3043 Chapter006NUR 3043 Chapter006
NUR 3043 Chapter006
 
NUR 3043 Chapter004
NUR 3043 Chapter004NUR 3043 Chapter004
NUR 3043 Chapter004
 
3043 Chapter009
3043 Chapter0093043 Chapter009
3043 Chapter009
 
3043 Chapter008
 3043 Chapter008 3043 Chapter008
3043 Chapter008
 
Melnyk ppt chapter_21
Melnyk ppt chapter_21Melnyk ppt chapter_21
Melnyk ppt chapter_21
 
Melnyk ppt chapter_22
Melnyk ppt chapter_22Melnyk ppt chapter_22
Melnyk ppt chapter_22
 

Ppt chapter 45

  • 1. Chapter 45 Drugs Treating Viral Infections Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 2. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • The transcription phase of viral replication involves the change of RNA to DNA. – A. True – B. False
  • 3. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • A. True • Rationale: Transcription involves the change of ribonucleic acid (RNA) to deoxyribonucleic acid (DNA).
  • 4. Physiology of Viral Reproduction • The reproduction of viruses in humans requires five steps: – Adsorption – Penetration – Uncoating – Replication – Transcription Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 5. Viral Reproduction Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 6. Pathophysiology of Selected Viral Infections • Cytomegalovirus (CMV) – Type of herpesvirus – Asymptomatic in most individuals – Patients with AIDS or bone marrow transplant recipients, CMV can be fatal. – CMV infection during pregnancy may lead to birth defect or stillborn. – Most frequently causes retinitis, but also infects lungs, throat, brain, kidneys, gallbladder, liver, and colon Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 7. Pathophysiology of Selected Viral Infections (cont.) • Hepatitis – Five types: HAV, HBV, HCV, HDV, and HEV – Most common in the United States: HAV, HBV, and Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins HCV – Symptoms include jaundice, fatigue, abdominal pain, nausea, and anorexia. – HAV: spread via oral–fecal route – HBV and HCV: spread via blood or body fluids
  • 8. Pathophysiology of Selected Viral Infections (cont.) • Herpes simplex (HSV) – Two types: HSV-1 and HSV-2 – Characterized by the formation of painful vesicles; HSV-1 on or near the mouth, HSV-2 in the genital region • Herpes zoster – Acute unilateral and segmental inflammation of the dorsal root ganglia caused by infection with the herpesvirus varicella zoster (chickenpox) – Follow dermatomes of trunk and occasionally on arms and legs – Postherpetic neuralgia is common complication. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 9. Pathophysiology of Selected Viral Infections (cont.) • Influenza – Attacks both the upper and the lower respiratory tracts – A and B only types affected by current antiviral agents • Respiratory syncytial virus (RSV) – A major cause of respiratory illness in all age groups – Highest rates of RSV illness occur in infants 2 to 6 months of age – Symptoms include hacking cough and wheezing on exhalation. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 10. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Hepatitis A is spread through blood and body fluids that contain blood. – A. True – B. False
  • 11. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • B. False • Rationale: Hepatitis A is spread by the oral and fecal route, not through blood or body fluids that contain blood.
  • 12. Purine Nucleoside Analogue Drugs • The largest group of antiviral drugs is the purine nucleoside analogue drugs. • They have relatively selective toxicity to viruses because viral DNA polymerases are more sensitive than human polymerases to inhibition by these drugs. • Prototype drug: acyclovir (Zovirax) Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 13. Acyclovir: Core Drug Knowledge • Pharmacotherapeutics – Treatment of herpesviruses • Pharmacokinetics – Administered: topical, oral, or IV • Pharmacodynamics – Undergoes phosphorylation. In an infected cell, it is converted by the viral enzyme thymidine kinase. Once incorporated into the virus, it terminates DNA synthesis. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 14. Acyclovir: Core Drug Knowledge (cont.) • Contraindications and precautions – Use caution in patients with ganciclovir hypersensitivity • Adverse effects – Light-headedness, anorexia, nausea, vomiting, abdominal pain, and headache • Drug interactions – Valproic acid, hydantoins, theophyllines, and probenecid Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 15. Acyclovir: Core Patient Variables • Health status – Assess medical history and function of kidneys. • Life span and gender – Pregnancy Category C drug • Lifestyle, diet, and habits – Can transmit disease to others • Environment – Assess the environment where the drug will be given. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 16. Acyclovir: Nursing Diagnoses and Outcomes • Disturbed Thought Processes related to drug-induced confusion, hallucinations, or seizures – Desired outcome: The patient will be free of thought aberrations related to drug therapy. • Acute Pain related to drug-induced headache – Desired outcome: Drug-related pain will subside after administration of acetaminophen. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 17. Acyclovir: Nursing Diagnoses and Outcomes (cont.) • Imbalanced nutrition: Less than Body Requirements, related to acyclovir-related anorexia, nausea and vomiting, or abdominal pain – Desired outcome: The patient will remain within an acceptable weight range. • Excess Fluid Volume related to adverse effects of drug therapy, such as nephrotoxicity – Desired outcome: The patient will have an adequate fluid intake and output profile. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 18. Acyclovir: Planning and Interventions • Maximizing therapeutic effects – Administer acyclovir tablets or capsules with a full glass of water, with or without food. • Minimizing adverse effects – Advise the patient to drink at least 8-oz glasses of water a day. – Administer IV acyclovir over 60 minutes. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 19. Acyclovir: Teaching, Assessment, and Evaluations • Patient and family education – Advise patients to notify the prescriber if they are pregnant or breast-feeding. – Emphasize that acyclovir does not prevent the transmission of infection to another person and does not cure the infection. • Ongoing assessment and evaluation – Monitor for the effectiveness of therapy, making sure to document new lesions and assess for possible secondary bacterial infections. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 20. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • IV acyclovir is associated with which of the following adverse reaction(s)? – A. Hepatotoxicity – B. Hallucinations – C. Nephrotoxicity – D. Seizures – E. Both B and D
  • 21. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • C. Nephrotoxicity • Rationale: Acyclovir nephrotoxicity appears to result from crystallization of the drug in the nephron, which can lead to renal tubular obstruction.
  • 22. Drugs Used for Influenza • Influenza can be a debilitating virus. • It generally subsides without pharmacotherapy. • Certain populations require treatment due to possible life-threatening symptoms. • Prototype: oseltamivir (Tamiflu) Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 23. Oseltamivir: Core Drug Knowledge • Pharmacotherapeutics – A neuraminidase inhibitor; used to manage influenza A or B virus; drug of choice for H5N1 and H1N1 • Pharmacokinetics – Metabolized: oseltamivir carboxylate. Excreted: Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins kidneys. • Pharmacodynamics – Appears to inhibit the release of viruses from infected cells, reducing spread to adjacent cells
  • 24. Oseltamivir: Core Drug Knowledge (cont.) • Contraindications and precautions – Hypersensitivity, pregnancy, breast-feeding, asthma, CAL, renal insufficiency • Adverse effects – Nausea and vomiting, bronchitis, insomnia, vertigo • Drug interactions – No known significant drug–drug interactions Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 25. Oseltamivir: Core Patient Variables • Health status – Assess for influenza symptoms. • Life span and gender – Pregnancy Category C drug • Lifestyle, diet, and habits – Assess for history of fructose intolerance. • Environment – Assess where the patient will be receiving the drug. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 26. Oseltamivir: Nursing Diagnoses and Outcomes • Disturbed Thought Processes related to drug-induced confusion, hallucinations, or seizures – Desired outcome: The patient will be free of thought aberrations related to drug therapy. • Risk for Injury related to abnormal behaviors – Desired outcome: The patient will remain free from Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins injury.
  • 27. Oseltamivir: Nursing Diagnoses and Outcomes (cont.) • Imbalanced nutrition: Less than Body Requirements, related to anorexia, nausea and vomiting, or abdominal pain – Desired outcome: The patient will remain within an acceptable weight range. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 28. Oseltamivir: Planning and Intervention • Maximizing therapeutic effects – Works best when started within 48 hrs of onset of symptoms – Prepare and store solution correctly. • Minimizing adverse effects – Reduce nausea and vomiting by administrating the drug with milk, a snack, or a meal. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 29. Oseltamivir: Teaching, Assessment, and Evaluations • Patient and family education – Instruct on the correct usage. – Encourage the patient to complete the full course. • Ongoing assessment and evaluation – Monitor for adverse effects. – Assess for resolution of symptoms. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins
  • 30. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Question • Which of the following symptoms are common for influenza? – A. Fever – B. Joint aches – C. Headache – D. All of the above
  • 31. Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Answer • D. All of the above • Rationale: Common signs and symptoms for influenza can include sudden onset, fever, dry cough, headache, muscle and joint aches, fatigue and weakness, extreme exhaustion, chest discomfort, stuffy nose, sneezing, and sore throat.